Detailed information for compound 37187

Basic information

Technical information
  • TDR Targets ID: 37187
  • Name: (1S,3R,4R,5S)-1,3,4-trihydroxy-5-(phosphonome thyl)cyclohexane-1-carboxylic acid
  • MW: 270.174 | Formula: C8H15O8P
  • H donors: 6 H acceptors: 8 LogP: -3.32 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 2
  • SMILES: OC1C(CP(=O)(O)O)CC(CC1O)(O)C(=O)O
  • InChi: 1S/C8H15O8P/c9-5-2-8(13,7(11)12)1-4(6(5)10)3-17(14,15)16/h4-6,9-10,13H,1-3H2,(H,11,12)(H2,14,15,16)
  • InChiKey: BKLICLLAHMTUPK-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • Carbaphosphonate
  • 1,3,4-trihydroxy-5-(phosphonomethyl)cyclohexane-1-carboxylic acid
  • 1,3,4-trihydroxy-5-(phosphonomethyl)cyclohexanecarboxylic acid
  • 1,3,4-trihydroxy-5-(phosphonomethyl)-1-cyclohexanecarboxylic acid

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Escherichia coli 3-dehydroquinate synthase Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Neospora caninum 3-dehydroquinate synthase (EC 4.2.3.4), related Get druggable targets OG5_127183 All targets in OG5_127183
Mycobacterium ulcerans 3-dehydroquinate synthase Get druggable targets OG5_127183 All targets in OG5_127183
Toxoplasma gondii shikimate dehydrogenase substrate binding domain-containing protein Get druggable targets OG5_127183 All targets in OG5_127183
Mycobacterium leprae probable 3-phosphoshikimate 1-carboxyvinyl transferase AroA (5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE) (EPSP SYNTHASE) (EPSPS Get druggable targets OG5_127183 All targets in OG5_127183
Mycobacterium tuberculosis 3-phosphoshikimate 1-carboxyvinyltransferase AroA (5-enolpyruvylshikimate-3-phosphate synthase) (EPSP synthase) (EPSPS) Get druggable targets OG5_127183 All targets in OG5_127183
Candida albicans similar to S. cerevisiae ARO1 pentafunctional aromatic amino acid family biosynthesis protein Get druggable targets OG5_127183 All targets in OG5_127183
Mycobacterium ulcerans 3-phosphoshikimate 1-carboxyvinyltransferase Get druggable targets OG5_127183 All targets in OG5_127183
Mycobacterium tuberculosis 3-dehydroquinate synthase AroB Get druggable targets OG5_127183 All targets in OG5_127183
Candida albicans similar to S. cerevisiae ARO1 pentafunctional aromatic amino acid family biosynthesis protein Get druggable targets OG5_127183 All targets in OG5_127183
Chlamydia trachomatis phosphoshikimate 1-carboxyl vinyltransferase Get druggable targets OG5_127183 All targets in OG5_127183
Schistosoma mansoni 3-dehydroquinate synthase Get druggable targets OG5_127183 All targets in OG5_127183
Mycobacterium leprae 3-dehydroquinate synthase AroB Get druggable targets OG5_127183 All targets in OG5_127183
Chlamydia trachomatis dehyroquinate synthase Get druggable targets OG5_127183 All targets in OG5_127183

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica adenosine deaminase, putative 0.0172 0.2726 0.5
Schistosoma mansoni 3-dehydroquinate synthase 0.0258 1 1
Onchocerca volvulus Adenosine deaminase homolog 0.0172 0.2726 0.5
Echinococcus multilocularis adenosine deaminase 0.0172 0.2726 0.5
Mycobacterium leprae Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) 0.0172 0.2726 0.2726
Mycobacterium tuberculosis Probable adenosine deaminase Add (adenosine aminohydrolase) 0.0172 0.2726 0.2726
Plasmodium vivax adenosine deaminase, putative 0.0172 0.2726 0.5
Treponema pallidum adenosine deaminase 0.0172 0.2726 0.5
Loa Loa (eye worm) hypothetical protein 0.0172 0.2726 0.5
Toxoplasma gondii shikimate dehydrogenase substrate binding domain-containing protein 0.0258 1 1
Plasmodium falciparum adenosine deaminase 0.0172 0.2726 0.5
Mycobacterium ulcerans adenosine deaminase 0.0172 0.2726 0.2726
Entamoeba histolytica adenosine deaminase, putative 0.0172 0.2726 0.5
Echinococcus granulosus adenosine deaminase 0.0172 0.2726 0.5
Brugia malayi Adenosine/AMP deaminase family protein 0.0172 0.2726 0.5
Trichomonas vaginalis adenosine deaminase, putative 0.0172 0.2726 0.5
Mycobacterium leprae 3-dehydroquinate synthase AroB 0.0258 1 1
Leishmania major adenine aminohydrolase 0.0172 0.2726 0.5
Trichomonas vaginalis adenosine deaminase, putative 0.0172 0.2726 0.5
Mycobacterium ulcerans 3-dehydroquinate synthase 0.0258 1 1
Mycobacterium tuberculosis 3-dehydroquinate synthase AroB 0.0258 1 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible ChEMBL. No reference
Inhibition (binding) R 0 Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible ChEMBL. No reference
Ki (binding) = 0.0000000054 M Inhibition constant of the compound was determined against 3-dehydroquinate synthase ChEMBL. No reference
Ki (binding) = 0.0000000054 M Inhibition constant of the compound was determined against 3-dehydroquinate synthase ChEMBL. No reference
Koff (binding) = 0.00075 s-1 Association rate constant of the compound was determined against 3-dehydroquinate synthase ChEMBL. No reference
Kon (binding) = 140000 M-1 s-1 Rate constant of the compound was determined against 3-dehydroquinate synthase ChEMBL. No reference
k_off (binding) = 0.00075 s-1 Association rate constant of the compound was determined against 3-dehydroquinate synthase ChEMBL. No reference
k_on (binding) = 140000 M-1 s-1 Rate constant of the compound was determined against 3-dehydroquinate synthase ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.